198 related articles for article (PubMed ID: 17132219)
1. Enhanced delivery of nebulised salbutamol during non-invasive ventilation.
Calvert LD; Jackson JM; White JA; Barry PW; Kinnear WJ; O'Callaghan C
J Pharm Pharmacol; 2006 Nov; 58(11):1553-7. PubMed ID: 17132219
[TBL] [Abstract][Full Text] [Related]
2. In-vitro characterisation of the nebulised dose during non-invasive ventilation.
Abdelrahim ME; Plant P; Chrystyn H
J Pharm Pharmacol; 2010 Aug; 62(8):966-72. PubMed ID: 20663030
[TBL] [Abstract][Full Text] [Related]
3. Albuterol delivery during noninvasive ventilation.
Branconnier MP; Hess DR
Respir Care; 2005 Dec; 50(12):1649-53. PubMed ID: 16318646
[TBL] [Abstract][Full Text] [Related]
4. Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation.
Ari A; Atalay OT; Harwood R; Sheard MM; Aljamhan EA; Fink JB
Respir Care; 2010 Jul; 55(7):845-51. PubMed ID: 20587095
[TBL] [Abstract][Full Text] [Related]
5. Bronchodilator delivery during simulated pediatric noninvasive ventilation.
White CC; Crotwell DN; Shen S; Salyer J; Yung D; Zheng J; DiBlasi RM
Respir Care; 2013 Sep; 58(9):1459-66. PubMed ID: 23386733
[TBL] [Abstract][Full Text] [Related]
6. Effects of ventilator settings, nebulizer and exhalation port position on albuterol delivery during non-invasive ventilation: an in-vitro study.
Sutherasan Y; Ball L; Raimondo P; Caratto V; Sanguineti E; Costantino F; Ferretti M; Kacmarek RM; Pelosi P
BMC Pulm Med; 2017 Jan; 17(1):9. PubMed ID: 28068958
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of bronchodilator drug delivery by jet nebulization during pediatric mechanical ventilation.
Di Paolo ER; Pannatier A; Cotting J
Pediatr Crit Care Med; 2005 Jul; 6(4):462-9. PubMed ID: 15982436
[TBL] [Abstract][Full Text] [Related]
8. Nebuliser performance, pharmacokinetics, airways and systemic effects of salbutamol given via a novel nebuliser delivery system ("Ventstream").
Newnham DM; Lipworth BJ
Thorax; 1994 Aug; 49(8):762-70. PubMed ID: 8091320
[TBL] [Abstract][Full Text] [Related]
9. Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit.
Rabea H; Ali AM; Salah Eldin R; Abdelrahman MM; Said AS; Abdelrahim ME
Eur J Pharm Sci; 2017 Jan; 97():182-191. PubMed ID: 27866986
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized albuterol sulfate delivery under neonatal ventilatory conditions: in vitro evaluation of a novel ventilator circuit patient interface connector.
Mazela J; Chmura K; Kulza M; Henderson C; Gregory TJ; Moskal A; Sosnowski TR; Florek E; Kramer L; Keszler M
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):58-65. PubMed ID: 23509937
[TBL] [Abstract][Full Text] [Related]
11. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With a Single-Limb Circuit.
Berlinski A; Velasco J
Respir Care; 2019 Nov; 64(11):1366-1370. PubMed ID: 31113855
[TBL] [Abstract][Full Text] [Related]
12. Albuterol delivery via intrapulmonary percussive ventilator and jet nebulizer in a pediatric ventilator model.
Berlinski A; Willis JR
Respir Care; 2010 Dec; 55(12):1699-704. PubMed ID: 21122179
[TBL] [Abstract][Full Text] [Related]
13. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask.
Parkes SN; Bersten AD
Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480
[TBL] [Abstract][Full Text] [Related]
14. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
[TBL] [Abstract][Full Text] [Related]
15. Delivered dose with jet and mesh nebulisers during spontaneous breathing, noninvasive ventilation and mechanical ventilation using adult lung models.
Ari A; Fink JB
ERJ Open Res; 2021 Jul; 7(3):. PubMed ID: 34262965
[TBL] [Abstract][Full Text] [Related]
16. Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.
Bhavna ; Ahmad FJ; Mittal G; Jain GK; Malhotra G; Khar RK; Bhatnagar A
Eur J Pharm Biopharm; 2009 Feb; 71(2):282-91. PubMed ID: 18984050
[TBL] [Abstract][Full Text] [Related]
17. Best BETs from the Manchester Royal Infirmary. BET 2. Is nebulised salbutamol indicated in bronchiolitis?
Panickar J
Emerg Med J; 2008 Dec; 25(12):840-1. PubMed ID: 19033508
[No Abstract] [Full Text] [Related]
18. Effects of inhalational bronchodilator treatment during noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations.
Mukhopadhyay A; Dela Pena E; Wadden B; Procyshyn M; Keang Lim T
J Crit Care; 2009 Sep; 24(3):474.e1-5. PubMed ID: 19664528
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of in vitro in vivo correlations for dry powder inhaler delivery using artificial neural networks.
de Matas M; Shao Q; Richardson CH; Chrystyn H
Eur J Pharm Sci; 2008 Jan; 33(1):80-90. PubMed ID: 18035525
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the need to coat particle collection cups of the NGI to mitigate droplet bounce when evaluating nebuliser-produced droplets.
Berg E; Lamb P; Ali A; Dennis J; Tservistas M; Mitchell J
Pharmeur Sci Notes; 2008 Feb; 2008(1):21-5. PubMed ID: 18430403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
